FIELD: medicine.
SUBSTANCE: tumour tissue is detected for total proteasome activity, 20S proteasome activity and NF-κB p50, HIF-1α expression, and discriminant functions Y1, Y2 are calculated by equations. If observing Y1>Y2, the absence of lymphogenic metastases is predicted, while Y1<Y2 enables predicting developing lymphogenic metastases.
EFFECT: higher prediction accuracy.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPING HAEMATOGENOUS METASTASES FOLLOWING COMBINED TREATMENT OF KIDNEY CANCER | 2013 |
|
RU2528100C1 |
| METHOD OF PERSONIFIED PRESCRIBING OF TARGETED THERAPY AGENTS IN PATIENTS WITH METASTATIC KIDNEY CANCER IN PREOPERATIVE MODE | 2017 |
|
RU2650964C1 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOME OF CHEMORADIATION THERAPY OF SQUAMOUS CELL CARCINOMA OF HEAD AND NECK | 2012 |
|
RU2505818C2 |
| METHOD FOR DISTANT METASTASES DEVELOPMENT RISK DEGREE DETERMINATION FOR PATIENTS WITH COLON CANCER | 2016 |
|
RU2623119C1 |
| METHOD OF PREDICTING EFFICIENCY OF PRE-OPERATION RADIOTHERAPY OF SQUAMOUS CELL CARCINOMAS OF HEAD AND NECK | 2012 |
|
RU2506902C2 |
| METHOD FOR EVALUATING THE DEGREE OF RISK OF ADVERSE EVALUATION OF DISEASE IN PATIENTS WITH GASTRIC CANCER | 2016 |
|
RU2662085C1 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOMES OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS | 2009 |
|
RU2426991C2 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF PROGRESSION IN A LONG PERIOD IN PATIENTS WITH SQUARE CELL CANCER OF THE HEAD AND NECK | 2021 |
|
RU2765013C1 |
| METHOD FOR PREDICTING THE COURSE OF THE DISEASE IN PATIENTS WITH LOCAL RENAL CELL CARCINOMA OF THE KIDNEY | 2018 |
|
RU2674677C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING DISTANT METASTASES IN PATIENTS WITH OPERABLE FORMS OF BREAST CANCER WITH METASTASES IN REGIONAL LYMPH NODES | 2020 |
|
RU2733697C1 |
